Cargando…
Efficacy of Combination Therapy with Oseltamivir Phosphate and Azithromycin for Influenza: A Multicenter, Open-Label, Randomized Study
BACKGROUND: Macrolides have antibiotic and immunomodulatory activities, which may have a favorable effect on the clinical outcome of patients with infections, including influenza. This study aimed to evaluate the effects of combination therapy with an anti-influenza agent, oseltamivir, and a single-...
Autores principales: | Kakeya, Hiroshi, Seki, Masafumi, Izumikawa, Koichi, Kosai, Kosuke, Morinaga, Yoshitomo, Kurihara, Shintaro, Nakamura, Shigeki, Imamura, Yoshifumi, Miyazaki, Taiga, Tsukamoto, Misuzu, Yanagihara, Katsunori, Tashiro, Takayoshi, Kohno, Shigeru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954629/ https://www.ncbi.nlm.nih.gov/pubmed/24632748 http://dx.doi.org/10.1371/journal.pone.0091293 |
Ejemplares similares
-
A mortality prediction rule for non-elderly patients with community-acquired pneumonia
por: Tashiro, Masato, et al.
Publicado: (2016) -
Efficacy and Safety of Intravenous Peramivir Compared With Oseltamivir in High-Risk Patients Infected With Influenza A and B Viruses: A Multicenter Randomized Controlled Study
por: Nakamura, Shigeki, et al.
Publicado: (2017) -
Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-α inhibitor: a case report
por: Takazono, Takahiro, et al.
Publicado: (2014) -
Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas aeruginosa
por: Kosai, Kosuke, et al.
Publicado: (2018) -
Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas Aeruginosa
por: Kosai, Kosuke, et al.
Publicado: (2017)